Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAREO study of intratumoral paclitaxel pharmacokinetics in oesophageal cancer
NL-OMON20604Recruiting
- Sponsor
- Erasmus MC
- Start
- Mar 2017
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of paclitaxel and carboplatin in esophageal cancer, sponsored by Erasmus MC. Started Mar 2017; status: recruiting.
02
Drugs
paclitaxelcarboplatin
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NL-OMON20604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20604.